United States [UAMY] vs IperionX Ltd - ADR [IPX] Detailed Stock Comparison

United States

NYSE
Loading...

IperionX Ltd - ADR

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: United States wins in 10 metrics, IperionX Ltd - ADR wins in 4 metrics, with 0 ties. United States appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricUnited StatesIperionX Ltd - ADRBetter
P/E Ratio (TTM)32.66-45.99IperionX Ltd - ADR
Price-to-Book Ratio24.60190.97United States
Debt-to-Equity Ratio2.594.26United States
PEG Ratio-1.81-172.47IperionX Ltd - ADR
EV/EBITDA-8,843.59-486.35United States
Profit Margin (TTM)-3.43%0.00%IperionX Ltd - ADR
Operating Margin (TTM)0.19%0.00%United States
EBITDA Margin (TTM)0.19%N/AN/A
Return on Equity-2.79%-49.17%United States
Return on Assets (TTM)-2.63%-30.59%United States
Free Cash Flow (TTM)$1.79M$-26.68MUnited States
1-Year Return919.74%140.69%United States
Price-to-Sales Ratio (TTM)38.78N/AN/A
Enterprise Value$929.62M$18.38BIperionX Ltd - ADR
EV/Revenue Ratio36.13N/AN/A
Gross Profit Margin (TTM)26.96%N/AN/A
Revenue per Share (TTM)$0N/AN/A
Earnings per Share (Diluted)$-0.01$-1.20United States
Beta (Stock Volatility)-0.100.35United States
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

United States vs IperionX Ltd - ADR Stock Performance Analysis

Loading Price Chart...

United States
IperionX Ltd - ADR
United States Stock Overview | IperionX Ltd - ADR Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
United States3.20%24.00%79.81%249.10%232.62%347.98%
IperionX Ltd - ADR3.00%8.75%15.41%83.78%250.64%55.90%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
United States919.74%2,052.78%1,745.24%1,790.24%1,481.63%1,514.58%
IperionX Ltd - ADR140.69%959.31%806.24%806.24%806.24%806.24%

News Based Sentiment: United States vs IperionX Ltd - ADR

United States

News based Sentiment: POSITIVE

The $245 million DLA contract is a game-changer for United States Antimony, securing a significant revenue stream and validating its position in the market. Coupled with expansion plans and positive analyst revisions, this month represents a major turning point for the company and its investors.

View United States News Sentiment Analysis

IperionX Ltd - ADR

News based Sentiment: POSITIVE

October was a demonstrably positive month for IperionX, characterized by a significant increase in share price, analyst upgrades, substantial institutional investment, and continued government funding. These factors collectively suggest growing confidence in the company's prospects and its ability to execute its strategic vision.

View IperionX Ltd - ADR News Sentiment Analysis

Performance & Financial Health Analysis: United States vs IperionX Ltd - ADR

MetricUAMYIPX
Market Information
Market Cap i$997.64M$1.07B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i12,307,53098,230
90 Day Avg. Volume i8,391,010114,590
Last Close$7.75$55.19
52 Week Range$0.49 - $8.40$12.27 - $56.78
% from 52W High-7.74%-2.80%
All-Time High$8.40 (Oct 03, 2025)$56.78 (Oct 03, 2025)
% from All-Time High-7.74%-2.80%
Growth Metrics
Quarterly Revenue Growth1.87%N/A
Quarterly Earnings Growth-0.11%N/A
Financial Health
Profit Margin (TTM) i-0.03%0.00%
Operating Margin (TTM) i0.00%0.00%
Return on Equity (TTM) i-0.03%-0.49%
Debt to Equity (MRQ) i2.594.26
Cash & Liquidity
Book Value per Share (MRQ)$0.32$0.29
Cash per Share (MRQ)$0.06$0.16
Operating Cash Flow (TTM) i$-767,649$-21,797,684
Levered Free Cash Flow (TTM) i$-8,479,040$-27,480,356
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: United States vs IperionX Ltd - ADR

MetricUAMYIPX
Price Ratios
P/E Ratio (TTM) i32.66-45.99
Forward P/E i13.84-172.47
PEG Ratio i-1.81-172.47
Price to Sales (TTM) i38.78N/A
Price to Book (MRQ) i24.60190.97
Market Capitalization
Market Capitalization i$997.64M$1.07B
Enterprise Value i$929.62M$18.38B
Enterprise Value Metrics
Enterprise to Revenue i36.13N/A
Enterprise to EBITDA i-8,843.59-486.35
Risk & Other Metrics
Beta i-0.100.35
Book Value per Share (MRQ) i$0.32$0.29

Financial Statements Comparison: United States vs IperionX Ltd - ADR

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)UAMYIPX
Revenue/Sales i$7.00MN/A
Cost of Goods Sold i$4.63MN/A
Gross Profit i$2.37MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$357,492N/A
EBITDA i$638,962N/A
Pre-Tax Income i$546,524N/A
Income Tax i$0N/A
Net Income (Profit) i$546,524N/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)UAMYIPX
Cash & Equivalents i$18.75M$33.16M
Total Current Assets i$24.84M$41.55M
Total Current Liabilities i$4.72M$3.05M
Long-Term Debt i$456,625$1.04M
Total Shareholders Equity i$32.59M$51.34M
Retained Earnings i$-40.60M$-73.88M
Property, Plant & Equipment i$410,573$8.60M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)UAMYIPX
Operating Cash Flow i$-929,407N/A
Capital Expenditures i$-862,011$-4.56M
Free Cash Flow i$-2.59M$-11.08M
Debt Repayment i$-32,632$-149,000
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricUAMYIPX
Shares Short i17.14M101,411
Short Ratio i2.981.20
Short % of Float i0.14%0.00%
Average Daily Volume (10 Day) i12,307,53098,230
Average Daily Volume (90 Day) i8,391,010114,590
Shares Outstanding i112.95M32.94M
Float Shares i101.35M266.36M
% Held by Insiders i0.17%0.00%
% Held by Institutions i0.27%0.12%

Dividend Analysis & Yield Comparison: United States vs IperionX Ltd - ADR

MetricUAMYIPX
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.40
3-Year Avg Dividend Yield iN/A2.70%
3-Year Total Dividends iN/A$1.20
Ex-Dividend DateN/AMar 01, 2024